Actively Recruiting
Assessment of Informal Support Provided by Caregivers at Different Stages of Alzheimer's Disease
Led by Hospices Civils de Lyon · Updated on 2026-02-13
312
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the amount and impact of informal care provided by family members or caregivers to patients with Alzheimer's disease, particularly at different stages of the condition. This research focuses on patients aged 60 and older diagnosed with dementia due to clinically probable Alzheimer's disease, who have varying degrees of cognitive decline as measured by the Mini-Mental State Evaluation (MMSE). The study aims to understand how cognitive decline, loss of autonomy, comorbidities, behavioral issues, and caregiver burden influence the use and cost of informal care. The study involves patients from Charpennes Hospital who are part of the MEM-AURA cohort, all accompanied by a caregiver. Researchers collect data using the "Ressources Utilisation in Dementia" (RUD) questionnaire, which gathers information on the use of services available to dementia patients. The primary focus is on measuring informal care costs at the start of the study or within 15 days after inclusion. Participants will be involved through their inclusion in the cohort and completion of questionnaires about care resources and costs. Researchers will assess the economic burden of informal care and analyze the clinical factors affecting it in Alzheimer's patients. The study will track informal care costs as the main outcome, while safety and withdrawal criteria are monitored throughout the study period, which starts in September 2025 and ends in September 2027.
CONDITIONS
Brief Title
Assessment of Informal Support Provided by Caregivers at Different Stages of Alzheimer's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients from Charpennes Hospital included in the MEM-AURA cohort
- Patients aged 60 years and older at inclusion
- Patients with dementia due to clinically probable Alzheimer's disease, regardless of stage
- Patients with a Mini-Mental State Evaluation (MMSE) score 6 at inclusion
- Patients accompanied by a caregiver at inclusion
You will not qualify if you...
- Patients or caregivers who have expressed their opposition to the study
- Patients living in institutions or nursing homes
- Patients protected by law (under legal protection, guardianship, or conservatorship)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 15 days after inclusion
Participants complete questionnaires assessing the use of services available to patients with dementia.
1 visit (in-person)
Duration - Up to several years until study completion
Participants and their caregivers are observed to assess informal support provided at different stages of Alzheimer's disease.
Visit schedule depends on study follow-up procedures
Trial Site Locations
Total: 1 location
1
Hôpital des Charpennes
Villeurbanne, France, 69100
Actively Recruiting
Research Team
G
GERVAIS F M Frédéric GERVAIS
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here